Asher Chanan-Khan
CIK: 0001869837
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLRB
Cellectar Biosciences, Inc.
Director
Discretionary Trading P&L
Holdings
About Chanan-Khan Asher
Chanan-Khan Asher (SEC CIK 0001869837) files insider reports with the SEC as Director of Cellectar Biosciences, Inc. (CLRB).
Signal8 holds 2 ownership filings by Chanan-Khan Asher, all Form 4s, filed between Feb 18, 2025 and Jul 8, 2026. Those filings report 2 transactions, from Feb 14, 2025 to Jul 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Chanan-Khan Asher's filings is in FLORHAM PARK, NJ.
Recent filings by Chanan-Khan Asher
Other insiders filing for Cellectar Biosciences, Inc. (CLRB)
- Loren Stefan, Officer
- Kolean Chad J, CFO
- DRISCOLL FREDERICK W, Director
- CARUSO JAMES V, President & CEO
- Gu Andrew, Director
- Longcor Jarrod, Chief Operating Officer